Lisa is an award-winning biopharma journalist, editor and thought leadership specialist with more than 20 years’ experience covering the life sciences industry. A former Financial Times biotech correspondent and editor of Evaluate Vantage, she has deep expertise across drug development, investment, M&A, specialty pharma, regulation and emerging technologies. 

Alongside freelance journalism, Lisa now works with life sciences companies and executives to develop thought leadership, editorial strategy, articles, white papers and other content that turns complex industry issues into clear, compelling perspectives. She is also a regular conference moderator and industry commentator, having chaired panels at leading European life sciences events and spoken at BIO International.